Key Companies Covered in the Injectable Drug Delivery Market Research Report are Gerresheimer AG, West Pharmaceutical Services, Inc., Pfizer Inc., Insulet Corporation, BD, Ypsomed A, Eli Lily and Company, Elcam Medical, SHL Group and other key market players.

Pune, Feb. 11, 2020 (GLOBE NEWSWIRE) -- The global Injectable Drug Delivery Market size is prophesized to reach USD 1,135.1 billion by 2026, with a CAGR of 12.8% by 2026. This is attributable to the increasing prevalence of chronic diseases worldwide. This information is published in an upcoming report by Fortune Business Insights™ titled,” Injectable Drug Delivery Market Size, Share and Industry Analysis By Device Type (Conventional Injectable, Pre-filled Syringes, Auto-injectors, Pen-injectors, Others), By Application (Autoimmune Disorders, Diabetes, Pain Management, Aesthetic Treatments, Others), By Route of Administration (Subcutaneous, Intravenous, Intramuscular, Others), By End-User (Hospitals, Home Care Settings, Clinics, Others), and Regional Forecast 2019-2026.” According to the report, the market was valued at USD 440.5 billion in 2018. The rising demand for convenient and effective systems for delivering drugs to patients who are completely dependent on medicines daily is a major factor propelling the Injectable Drug Delivery Market growth.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/injectable-drug-delivery-market-101044

Objectives of the Report

• A qualitative and quantitative analysis of the Injectable Drug Delivery Market
• Growth drivers, restraints, and challenges of the market
• Detailed segmentation of the market based on factors such as device type, application, route of administration, end-user, and region.
• List of significant players and the strategies adopted by them to gain a competitive edge in the market
• Major Injectable Drug Delivery Market trends and opportunities
• Significant industry developments and interesting insights into the market.

Drivers –

Rise in Awareness among Patients about Minimally Invasive Injectables to Drive Market

As mentioned earlier, the increasing prevalence of chronic diseases worldwide is a major factor driving the market. Additionally, the advent of home healthcare and other convenient modes of health assistance have propelled the demand for medication at home. This further promoted the Injectable Drug Delivery Market growth. This, coupled with the rise in patient awareness about minimally invasive injectables, is expected to boost the market. Moreover, the rise in demand for self-injectable devices aided the expansion of the overall market. Furthermore, the introduction of both user-friendly and cost-friendly systems and their effective features such as on-target delivery are further fostering the growth of the market.

Additionally, the rapidly developing healthcare infrastructure and the advent of novel therapeutic drug delivery systems are prognosticated to create lucrative growth opportunities in the forthcoming years.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/injectable-drug-delivery-market-101044

Segment –

Conventional Injectable Segment to hold Dominant Position in Market

Based on device type, the market is categorized into pen-injectors, auto-injectors, pre-filled syringes, conventional injectable, and others. Among these, the conventional injectable segment is holding a majority of the Injectable Drug Delivery Market share. In 2018, this segment held a 34.0% share.

Regional Analysis –

High Rate of Adoption of Injectable Drug Technologies Will Help Dominate Market in North America

From a geographical viewpoint, the global Injectable Drug Delivery Market is widespread into the regions of Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa. Among these, the market is dominated by North America on account of the high rate of adoption of injectable drug technologies especially among patients suffering from diseases such as cancer, diabetes, and other autoimmune disorders in the region. The American Diabetes Association (ADA) estimates an approximate of 30.3 million Americans to be diagnosed with diabetes in 2018. This, coupled with the presence of major manufacturers in the region, is likely to help attract high Injectable Drug Delivery Market revenue in the future.

Competitive Landscape –

Heavy Investments to Develop Liquid Drugs and Vaccinations for Aesthetic Treatment will Set New Benchmark for Competitors

Injectable drug delivery systems are utilized for aesthetic treatment such as body shaping, skin tightening, and wrinkle treatment among others. The advancement in medical technology has introduced new treatment options to enter the patient’s body through various routes such as intramuscular, intravenous, or subcutaneous. Companies are investing huge sums into research and development of various antibiotics, liquid drugs, and vaccinations to treat aesthetic problems. Such investments will help players gain a competitive edge in the market and attract high revenue to the overall market in the long run.

List of Injectable Drug and Delivery Market Manufacturers are:

• Gerresheimer AG
• West Pharmaceutical Services, Inc.
• Pfizer Inc.
• Insulet Corporation
• BD
• Ypsomed A
• Eli Lily and Company
• Elcam Medical
• SHL Group
• Others

Industry Developments of Injectable Drug Delivery Market Include:

July 2019 – A D-MINE pump was launched by Ever Neuro Pharma GMBH for treating patients with Parkinson’s disease. This device issues continuous subcutaneous drug delivery and is convenient for patient use.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/injectable-drug-delivery-market-101044

Detailed Table of Content:

• Introduction
  • Research Scope
  • Market Segmentation
  • Research Methodology
  • Definitions and Assumptions
• Executive Summary
• Market Dynamics
  • Market Drivers
  • Market Restraints
  • Market Opportunities
• Key Insights
  • Prevalence of key diseases - For key countries, 2018
  • New product launch
  • Overview of technological advancements in injectable drug delivery
  • Pricing analysis
  • Key Industry Developments - Mergers, Acquisitions, and Partnerships, 2018
• Global Injectable Drug Delivery Market Analysis, Insights and Forecast, 2015-2026
  • Key Findings / Summary
  • Market Analysis, Insights and Forecast – By Device Type
    • Conventional Injectable
    • Pre-filled Syringes
    • Auto-injectors
    • Pen-injectors
    • Others
  • Market Analysis, Insights and Forecast – By Application
    • Autoimmune Disorders
    • Diabetes
    • Pain Management
    • Aesthetic Treatments
    • Others
  • Market Analysis, Insights and Forecast – By Route of Administration
    • Subcutaneous
    • Intravenous
    • Intramuscular
    • Others
  • Market Analysis, Insights and Forecast – By End-User
    • Hospitals
    • Home Care Settings
    • Clinics
    • Others
  • Market Analysis, Insights and Forecast – By Region
    • North America
    • Europe
    • Asia pacific
    • Latin America
    • Middle East & Africa

TOC Continued….!

Request for Customization:  https://www.fortunebusinessinsights.com/enquiry/customization/injectable-drug-delivery-market-101044

Have a Look at Related Reports:

Connected Drug Delivery Devices Market Size, Share & Industry Analysis, By Type (Injectable Devices and Inhalation Devices & Others) By Technology (Bluetooth, NFC, and Others) By End User (Homecare Settings and Hospitals) and Regional Forecast, 2019-2026

Pulmonary Drug Delivery Systems Market Size, Share and Global Trend by Types (Inhalers, Nebulizers), By Application (Cystic Fibrosis, Asthma, Chronic Obstructive Pulmonary Disorder (COPD)), By Age Group (Adult, Pediatric), By End User (Hospitals, Specialty Clinics, Home Care Services), and Geography Forecast till 2026

Transdermal Drug Delivery System Market Size, Share & Industry Analysis, By Type (Patches, Gels), By Application (Pain Management, Cardiovascular Diseases, Central Nervous System Diseases, Others), By End User (Hospitals, Clinics, Home Care Settings, Others) and Regional Forecast, 2019-2026

Needle-free Drug Delivery Technology Market Size, Share and Global Trend By Product (Inhaler, Jet Injector, Novel Needles, Transdermal Patch), By Application ( Vaccine Delivery, Pain Management, Insulin Delivery), By End Users (Hospitals & Clinics, Homecare Settings, Research Laboratories, Academics), and Geography Forecast till 2026

Magnetic Resonance Imaging (MRI) Systems Market Size, Share and Global Trend By Strength (Less than 1.5 T, 1.5 T & More than 1.5 T), Application (Musculoskeletal, Neurology, Cardiology, Body Imaging), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers) and Geography Forecast till 2025

Influenza Vaccine Market Size, Share & Industry Analysis, By Type (Inactivated and Live Attenuated), By Valency (Quadrivalent and Trivalent), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Geography Forecast, 2019-2026

Vaccines Market Size, Share & Industry Analysis, By Type (Recombinant/Conjugate/Subunit, Inactivated, Live Attenuated and Toxoid), By Route of Administration (Parenteral and Oral), By Disease Indication (Viral Diseases and Bacterial Diseases), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Region Forecast, 2019-2026

Connected Drug Delivery Devices Market Size, Share & Industry Analysis, By Type (Injectable Devices and Inhalation Devices & Others) By Technology (Bluetooth, NFC, and Others) By End User (Homecare Settings and Hospitals) and Regional Forecast, 2019-2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/injectable-drug-delivery-market-9202